Effects of piperazinedione (NSC 135785) plus irradiation on endogenous CFU-S, intestinal crypts, and as a possible ablative protocol for marrow transplantation as evaluated in Rauscher leukemic mice.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D001853:Bone Marrow / Q000187:drug effects; D016026:Bone Marrow Transplantation; D002470:Cell Survival / Q000187:drug effects / Q000528:radiation effects; D005260:Female; D007422:Intestines / Q000187:drug effects* / Q000528:radiation effects; D007942:Leukemia, Experimental / Q000401:mortality / Q000628:therapy*; D051379:Mice; D008871:Microvilli / Q000187:drug effects; D010879:Piperazines / Q000494:pharmacology*; D012008:Recurrence; D013154:Spleen / Q000187:drug effects* / Q000528:radiation effects; D013997:Time Factors; D014916:Whole-Body Irradiation; D014965:X-Rays
D000903:Antibiotics, Antineoplastic; D010879:Piperazines; C003905:3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione